HR 946 · 119th Congress 2025–2027

ORPHAN Cures Act

Latest action · Feb 6, 2025 Sponsor introductory remarks on measure. (CR H535-536)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 4, 2025
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act

This bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.

The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.

Cosponsors 18

Members who signed on, in the order they did. Signatures ran from Feb 4, 2025 to Sep 30, 2025; 9 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NCDonald G. DavisOriginalFeb 4, 2025
R-FLGus M. BilirakisOriginalFeb 4, 2025
D-NJJosh GottheimerOriginalFeb 4, 2025
R-OKKevin HernOriginalFeb 4, 2025
R-IAMariannette Miller-MeeksOriginalFeb 4, 2025
R-NCRichard HudsonOriginalFeb 4, 2025
D-CAScott H. PetersOriginalFeb 4, 2025
D-MIShri ThanedarOriginalFeb 4, 2025
D-MAWilliam R. KeatingOriginalFeb 4, 2025
D-NVDina TitusApr 7, 2025
D-ORJanelle S. BynumApr 7, 2025
R-PALloyd SmuckerApr 7, 2025
R-NJThomas H. Kean, Jr.Apr 7, 2025
D-ORAndrea SalinasMay 20, 2025
R-FLNeal P. DunnMay 20, 2025
D-CAAdam GrayJun 12, 2025
R-TXDan CrenshawJun 12, 2025
R-PARobert P. Bresnahan, Jr.Sep 30, 2025

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Feb 4, 2025
HouseWays and Means Committee
Referred Feb 4, 2025

Actions 3

Everything that happened, newest first.

  1. Feb 6, 2025Sponsor introductory remarks on measure. (CR H535-536)
  2. Feb 4, 2025Introduced in House
  3. Feb 4, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H535John Joyce R-PAFeb 6, 2025

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8 of the U.S. Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 23, February 4, 2025, page H460.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1862ORPHAN Cures ActRelated billMay 22, 2025

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.
Short Title(s) as Introduced
ORPHAN Cures Act
Optimizing Research Progress Hope And New Cures Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 4, 2025Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.